GlassScriptPhysician profile
David J Fuerst
NPI 1851376511
$10,022.21
in general payments reported to CMS, 2019-2025
19 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,273 · 2020: $3,507 · 2021: $950 · 2022: $644 · 2023: $1,674 · 2024: $380 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $4,227.43 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Istent Inject Trabecular Micro-Bypass System |
| Alcon Vision LLC | $4,042.26 | 2019-2025 | Ngenuity, Centurion, Clareon |
| Sight Sciences, INC. | $335.02 | 2021-2022 | |
| Allergan, INC. | $313.95 | 2019-2021 | |
| Ivantis, INC | $187.55 | 2019-2020 | |
| Biogen, INC. | $129.80 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $124.68 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $124.38 | 2019 | |
| Eyepoint US, INC. | $116.23 | 2021 | |
| Carl Zeiss Meditec, INC. | $94.55 | 2021-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $80.35 | 2019 | |
| Biotissue Holdings INC. | $78.48 | 2023 | |
| Nova Eye, INC. | $47.95 | 2024 | |
| Rxsight INC | $27.53 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Medtronic, INC. | $24.94 | 2025 | Progrip |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.58 | 2022 | |
| Boston Scientific Corporation | $18.45 | 2024 | Varithena Administration Pack |
| Oyster Point Pharma, INC. | $16.51 | 2022 | |
| Dompe US, INC. | $13.57 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fuerst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.